These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12722985)

  • 1. Sibutramine decreases body weight gain and increases energy expenditure in obese Zucker rats without changes in NPY and orexins.
    Casado A; Rodríguez VM; Portillo MP; Macarulla MT; Abecia LC; Echevarría E; Casis L
    Nutr Neurosci; 2003 Apr; 6(2):103-11. PubMed ID: 12722985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fluoxetine administration on neuropeptide y and orexins in obese zucker rat hypothalamus.
    Gutiérrez A; Saracíbar G; Casis L; Echevarría E; Rodríguez VM; Macarulla MT; Abecia LC; Portillo MP
    Obes Res; 2002 Jun; 10(6):532-40. PubMed ID: 12055330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sibutramine reduces feeding, body fat and improves insulin resistance in dietary-obese male Wistar rats independently of hypothalamic neuropeptide Y.
    Brown M; Bing C; King P; Pickavance L; Heal D; Wilding J
    Br J Pharmacol; 2001 Apr; 132(8):1898-904. PubMed ID: 11309262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sibutramine alters the central mechanisms regulating the defended body weight in diet-induced obese rats.
    Levin BE; Dunn-Meynell AA
    Am J Physiol Regul Integr Comp Physiol; 2000 Dec; 279(6):R2222-8. PubMed ID: 11080089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.
    Vickers SP; Webster LJ; Wyatt A; Dourish CT; Kennett GA
    Psychopharmacology (Berl); 2003 Apr; 167(1):103-11. PubMed ID: 12632249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite regulation of hypothalamic orexin and neuropeptide Y receptors and peptide expressions in obese Zucker rats.
    Beck B; Richy S; Dimitrov T; Stricker-Krongrad A
    Biochem Biophys Res Commun; 2001 Aug; 286(3):518-23. PubMed ID: 11511089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of moxonidine on feeding and body fat in obese Zucker rats: role of hypothalamic NPY neurones.
    Bing C; King P; Pickavance L; Brown M; Ziegler D; Kaan E; Williams G
    Br J Pharmacol; 1999 May; 127(1):35-42. PubMed ID: 10369453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate-treated obese female rats: relationship of antiobesity effect with monoamines.
    Nakagawa T; Ukai K; Ohyama T; Gomita Y; Okamura H
    Exp Anim; 2000 Oct; 49(4):239-49. PubMed ID: 11109549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of body weight and carcass composition by sibutramine in rats.
    Strack AM; Shu J; Camacho R; Gorski JN; Murphy B; MacIntyre DE; Hickey GJ
    Obes Res; 2002 Mar; 10(3):173-81. PubMed ID: 11886940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat.
    Raposinho PD; White RB; Aubert ML
    J Neuroendocrinol; 2003 Feb; 15(2):173-81. PubMed ID: 12535159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of isocaloric diets and sibutramine on food intake, body mass variation and serum TNF-alpha levels in rats.
    Trapali M; Liapi C; Perelas A; Perrea D; Stroubini T; Dontas I; Couvari E; Mavri M; Galanopoulou P
    Pharmacology; 2008; 82(1):15-21. PubMed ID: 18434760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of sibutramine on energy expenditure and body composition in obese adolescents.
    Van Mil EG; Westerterp KR; Kester AD; Delemarre-van de Waal HA; Gerver WJ; Saris WH
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1409-14. PubMed ID: 17264187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anorectic effect of metformin in obese Zucker rats: lack of evidence for the involvement of neuropeptide Y.
    Rouru J; Pesonen U; Koulu M; Huupponen R; Santti E; Virtanen K; Rouvari T; Jhanwar-Uniyal M
    Eur J Pharmacol; 1995 Jan; 273(1-2):99-106. PubMed ID: 7737322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orexins (hypocretins) directly interact with neuropeptide Y, POMC and glucose-responsive neurons to regulate Ca 2+ signaling in a reciprocal manner to leptin: orexigenic neuronal pathways in the mediobasal hypothalamus.
    Muroya S; Funahashi H; Yamanaka A; Kohno D; Uramura K; Nambu T; Shibahara M; Kuramochi M; Takigawa M; Yanagisawa M; Sakurai T; Shioda S; Yada T
    Eur J Neurosci; 2004 Mar; 19(6):1524-34. PubMed ID: 15066149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locomotion is the major determinant of sibutramine-induced increase in energy expenditure.
    Golozoubova V; Strauss F; Malmlöf K
    Pharmacol Biochem Behav; 2006 Apr; 83(4):517-27. PubMed ID: 16647108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orexins/hypocretins in the ob/ob mouse: hypothalamic gene expression, peptide content and metabolic effects.
    Stricker-Krongrad A; Richy S; Beck B
    Regul Pept; 2002 Mar; 104(1-3):11-20. PubMed ID: 11830271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin.
    Edwards CM; Abusnana S; Sunter D; Murphy KG; Ghatei MA; Bloom SR
    J Endocrinol; 1999 Mar; 160(3):R7-12. PubMed ID: 10077743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sibutramine-dependent brown fat activation in rats: an immunohistochemical study.
    Giordano A; Centemeri C; Zingaretti MC; Cinti S
    Int J Obes Relat Metab Disord; 2002 Mar; 26(3):354-60. PubMed ID: 11896490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y in central control of feeding and interactions with orexin and leptin.
    Niimi M; Sato M; Taminato T
    Endocrine; 2001 Mar; 14(2):269-73. PubMed ID: 11394646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleoyl-estrone does not alter hypothalamic neuropeptide Y in Zucker lean and obese rats.
    Cabot C; Grasa MM; Adán C; Pérez-Clausell J; Virgili J; Estruch J; Fernández-Löpez JA; Remesar X; Alemany M
    Peptides; 1998; 19(9):1631-5. PubMed ID: 9864070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.